Poddar Speciality Hospital Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 30-06-2024
- Paid Up Capital ₹ 1.62 M
as on 30-06-2024
- Company Age 14 Year, 27 Days
- Last Filing with ROC 31 Mar 2016
- Open Charges ₹ 2.08 Cr
as on 30-06-2024
- Revenue -17.11%
(FY 2016)
- Profit 245.68%
(FY 2016)
- Ebitda -3.85%
(FY 2016)
- Net Worth 6.02%
(FY 2016)
- Total Assets -1.67%
(FY 2016)
About Poddar Speciality Hospital
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2016. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.62 M.
The company currently has active open charges totaling ₹2.08 Cr.
Subrata Poddar, Nabnita Poddar, Jayanta Mohanta, and One other member serve as directors at the Company.
- CIN/LLPIN
U85110WB2010PTC155063
- Company No.
155063
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Nov 2010
- Date of AGM
30 Sep 2016
- Date of Balance Sheet
31 Mar 2016
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Cooch Behar, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Poddar Speciality Hospital?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subrata Poddar  | Director | Current | |
| Nabnita Poddar | Director | Current | |
| Jayanta Mohanta | Director | 08-Mar-2013 | Current |
| Somsubhra Poddar | Director | Current |
Financial Performance of Poddar Speciality Hospital.
Poddar Speciality Hospital Private Limited, for the financial year ended 2016, experienced significant reduction in revenue, with a 17.11% decrease. The company also saw a substantial improvement in profitability, with a 245.68% increase in profit. The company's net worth moved up by a moderate rise of 6.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Poddar Speciality Hospital?
In 2016, Poddar Speciality Hospital had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Poddar Fruits & Vegetables Product Private LimitedActive 23 years 5 monthsSubrata Poddar, Nabnita Poddar and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Allahabad Bank Creation Date: 27 Mar 2015 | ₹3.27 M | Open |
Allahabad Bank Creation Date: 25 Jun 2013 | ₹1.75 Cr | Open |
How Many Employees Work at Poddar Speciality Hospital?
Poddar Speciality Hospital has a workforce of 29 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Poddar Speciality Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Poddar Speciality Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
